- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00804323
PASCAL Trabeculoplasty
December 6, 2008 updated by: Asociación para Evitar la Ceguera en México
Semi-Automated Patterned Laser Trabeculoplasty
Argon laser trabeculoplasty (ALT) with 100 ms pulses is an effective therapy for lowering intraocular pressure (IOP).
Similar reductions in IOP have been achieved using ns (SLT) and microsecond (MLT) pulses, which produce less thermal damage to trabecular meshwork (TM).
Lack of clinically visible changes may make the accurate alignment of subsequent pulses difficult.
We describe a novel technique - Patterned Laser Trabeculoplasty (PLT) using the PASCAL Photocoagulator system, and its preliminary evaluation in patients with open angle glaucoma.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
24
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Felix Gil Carrasco, MD
- Phone Number: 1163 525510841400
- Email: glaucoma_apec@hotmail.com
Study Locations
-
-
DF
-
Mexico, DF, Mexico, 04030
- Recruiting
- Asociación Para Evitar la Ceguera en México
-
Contact:
- Felix Gil Carrasco, MD
- Phone Number: 1163 525510841400
- Email: glaucoma_apec@hotmail.com
-
Principal Investigator:
- Mauricio Turati Acosta, MD
-
Sub-Investigator:
- Adolfo Morales Gonzalez, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18-year-old patients
- Uncontrolled Open angle (Shaffer IV)
- No previous surgical trabeculoplasty or glaucoma surgery
Exclusion Criteria:
- Patients not willing to participate
- Angle-closure glaucoma
- No clear optical media
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group 1
Patients with open-angle glaucoma
|
Pattern Scan Laser trabeculoplasty
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Intraocular Pressure
Time Frame: During follow-up
|
During follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Felix Gil Carrasco, MD, Asociación Para Evitar la Ceguera en México
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2007
Primary Completion (Anticipated)
December 1, 2008
Study Completion (Anticipated)
December 1, 2009
Study Registration Dates
First Submitted
December 5, 2008
First Submitted That Met QC Criteria
December 5, 2008
First Posted (Estimate)
December 8, 2008
Study Record Updates
Last Update Posted (Estimate)
December 9, 2008
Last Update Submitted That Met QC Criteria
December 6, 2008
Last Verified
December 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APEC-041
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Open-Angle Glaucoma
-
AllerganRecruiting18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (ARGOS)Ocular Hypertension | Open-angle GlaucomaUnited States
-
Aerie PharmaceuticalsCompletedOcular Hypertension | Open-angle Glaucoma
-
West Virginia UniversityUniversity of Pittsburgh; University of MichiganWithdrawnOpen-angle Glaucoma
-
Glaukos CorporationUnknownOpen-Angle GlaucomaSpain, Germany, Austria, Turkey
-
Alcon ResearchWithdrawnOpen-Angle Glaucoma
-
Pharmaceutical Research NetworkCompleted
-
National Eye Institute (NEI)CompletedOpen-Angle Glaucoma
-
National Eye Institute (NEI)UnknownOpen-Angle Glaucoma
Clinical Trials on Patter Scan Laser System (OptiMedica, Santa Clara, CA, USA)
-
Assiut UniversityNot yet recruitingFemoropopliteal Occlusive DiseaseEgypt
-
Xuanwu Hospital, BeijingNot yet recruitingStroke | Carotid Stenosis | Carotid Artery StentChina
-
Fogarty Clinical Research Inc.Abbott Medical Devices; Helen Kay Foundation; Northern Michigan Hospital Foundation...Unknown
-
University of Turin, ItalyCompletedMaxillary Transverse Deficiency (MTD)Italy
-
Institut de Médecine et d'Epidémiologie Appliquée...Gilead Sciences; Roche Pharma AG; ANRS, Emerging Infectious Diseases; BioMérieux; Mairie de ParisCompletedLiver Cirrhosis | Hepatitis B | Carcinoma, HepatocellularFrance
-
Medical University of ViennaCompletedMacular Edema | Proliferative Diabetic RetinopathyAustria
-
Yonsei UniversityCompletedHigh-risk Patients for Post-ESD BleedingKorea, Republic of
-
Guangzhou Institute of Respiratory DiseaseThe Fifth Affiliated Hospital of Zunyi Medical CollegeCompletedCOPD | Metabolomics | Omega 3 | Omega 6
-
Instituto Nacional de Cardiologia Ignacio ChavezTerminatedCoronary Artery Disease (CAD) | Percutaneous Coronary Intervention (PCI) | High Bleeding RiskMexico